NCT07356245 Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma Status RECRUITING Phase PHASE2
NCT07047885 Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) Status RECRUITING Phase PHASE1
NCT06860880 Combating Cancer-Related Fatigue: A Personalized Supportive Care Program Status RECRUITING Phase NA
NCT06716658 JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas Status RECRUITING Phase PHASE2
NCT06665490 Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash Status ENROLLING_BY_INVITATION Phase N/A
NCT06651203 Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study Status NOT_YET_RECRUITING Phase N/A
NCT06588868 Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma Status RECRUITING Phase N/A
NCT06470451 Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL Status RECRUITING Phase PHASE3
NCT06436677 A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma Status RECRUITING Phase N/A
NCT06385522 A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System Status NOT_YET_RECRUITING Phase PHASE1
NCT06113081 Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma Status COMPLETED Phase N/A
NCT05956041 Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas Status RECRUITING Phase PHASE2
NCT05872854 Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light Status COMPLETED Phase PHASE2
NCT05781386 A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors Status RECRUITING Phase PHASE1
NCT05728879 Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT05414500 Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides Status RECRUITING Phase PHASE1
NCT05205902 TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides Status NOT_YET_RECRUITING Phase PHASE3
NCT04955340 A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat Status COMPLETED Phase PHASE1
NCT04045470 A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma Status RECRUITING Phase NA